Boston Scientific Corp. has commenced enrollment in the HI-PEITHO clinical trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing use of the EkoSonic Endovascular System in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk […]
Economic analyses from the WRAP-IT study, sponsored by Medtronic, demonstrate the Tyrx cardiac absorbable antibacterial envelope’s (Tyrx Envelope) cost effectiveness in European markets for patients at increased risk of infections.
New research from the ISAR-REACT 5 trial indicated that patients with ACS who received PCI had a lower composite endpoint of all-cause death, MI or stroke when given prasugrel vs. ticagrelor therapy.
As physicians and health policy experts debate the merits of Aduhelm, the first new drug for Alzheimer’s disease approved in 18 years, patients want to know: “Will this medication help me — and how much?”
Case Presentation: Endomyocardial fibrosis is an unusual etiology of heart failure. A detailed evaluation of diastolic function is key for diagnosis. The presence of fibrosis generates key functional alterations in the diagnosis. Multimodality imaging helps to establish severity and functional compromise.
Xeltis has started the first-ever pivotal trial for a synthetic restorative pulmonary valve. To date, pediatric patients requiring right ventricular outflow tract (RVOT) reconstruction have been successfully implanted as part of the global, FDA-approved Xplore2/Pivotal study. RVOT reconstruction is a procedure needed to correct certain congenital heart defects.
Myocarditis in children is a rare yet challenging condition to treat. Diagnosis and treatment includes multiple options, and many cases of myocarditis resolve on their own, according to a new scientific statement from the American Heart Association, “Diagnosis and Management of Myocarditis in Children,” published today in Circulation, the Association’s flagship journal.
Another observational study hints that patient selection and perfect technique can yield hard benefits, but RCT proof still lags.
Malignant or interarterial course of the large epicardial coronary arteries can cause myocardial ischemia, angina, acute coronary syndromes, congestive heart failure, or sudden cardiac death. This is a case of an 18-year-old healthy collegiate basketball player who presented with ventricular fibrillation and cardiogenic shock due to an interarterial and intramural course of an anomalous left […]
The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation AngelMed Guardian device. It is the world’s first implantable cardiac detection monitor and patient-warning system for acute coronary syndrome (ACS) events, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery […]
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!